[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356637-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356637-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multicenter-prospective-study-of-dedicated-breast-positron-emission-tomography-dbpet-for-breast-cancer-examination-in-preoperative-patients","Multicenter prospective study of dedicated breast positron emission tomography (dbPET) for breast cancer - examination in preoperative patients","","Dedicated breast positron emission tomography (dbPET) was developed to detect breast cancers smaller than those detectable with whole-body PET, yet criteria for identifying the patients who benefit most remain unclear. A multicenter, prospective exploratory study assessed how dbPET SUVmax relates to clinical characteristics, other imaging modalities, and pathological findings. Among 219 patients, correlations were evaluated to determine which factors and lesion-to-healthy (L/H) SUVmax metrics support patient selection and dbPET utilization.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multicenter-prospective-study-of-dedicated-breast-positron-emission-tomography-dbpet-for-breast-cancer-examination-in-preoperative-patients/356637/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multicenter-prospective-study-of-dedicated-breast-positron-emission-tomography-dbpet-for-breast-cancer-examination-in-preoperative-patients/356637.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main objective?","Question",{"text":63,"@type":64},"To determine which patient groups would benefit most from dbPET and how the modality should be utilized, by examining relationships between dbPET SUVmax and clinical, imaging, and pathological factors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many patients were included, and how were they categorized?",{"text":68,"@type":64},"The study included 219 breast cancer patients and divided them into three groups: primary care, neoadjuvant therapy, and postoperative follow-up patients.",{"name":70,"@type":61,"acceptedAnswer":71},"What did dbPET show regarding lesion detection and correlations with tumor biology?",{"text":72,"@type":64},"dbPET identified 100% of lesions, including benign findings. Ki-67 showed the strongest positive correlation with lesion-site dbPET SUVmax and with the dbPET SUVmax L/H ratio.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356637,1790798469,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Satou etal. BMC Medical Imaging (2026) 26:199 [https://doi.org/10.1186/s12880-026-02307-1](https://doi.org/10.1186/s12880-026-02307-1)  \nBMC Medical Imaging  \nRESEARCH Open Access  \nMulticenter prospective study of dedicated breast positron emission tomography (dbPET) for breast cancer: examination in preoperative patients  \nYouko Satou1,2*, Yuki Nakagami1,3, Kazuyoshi Suga4 and Yamaguchi Breast Cancer Study Group (YBC)  \nAbstract  \nBackground Dedicated breast positron emission tomography (dbPET) was developed to detect breast cancers smaller than those detectable using whole-body PET (wbPET) . Although several studies have explored the use of dbPET, clear criteria for identifying which patients would benefit most from this modality are lacking. Our objective was to determine which patient groups would benefit most from dbPET and how it should be utilized. We conducted a multicenter, prospective exploratory study to investigate how the dbPET maximum standardized uptake values (SUVmax) correlate with patients’ clinical characteristics, other imaging modalities, and pathological findings of the lesions.  \nMethods In total, 219 patients with breast cancer (median age [range], 58.0 [30–83] years) were included in this study. The enrolled patients were divided into three groups (primary care, neoadjuvant therapy, postoperative follow-up patients) . In this research, we examined the primary care group (n = 92) . To investigate which patient groups benefit from dbPET, we examined which factors influence and correlate with dbPET SUVmax. Depending on the items being compared, correlation analysis, Wilcoxon signed rank test was used to examine the following items. Which factors (physical factors, pathological characteristics, etc.) correlate with dbPET SUVmax, differences between dbPET and other imaging examination (detection rate, etc.), and whether dbPET SUVmax L/H ratio (Lesion-to-Healthy (normal) site dbPET SUVmax ratio) incorporating dbPET SUVmax from healthy (normal) mammary gland tissue are necessary for evaluating dbPET SUVmax in lesion areas.  \nResults dbPET SUVmax in healthy(normal) mammary gland tissue were strongly associated with background mammary density observed on mammography (MMG) examination (positive correlation, p\u003C0 . 05) . Ki-67 showed the strongest positive correlation with both the lesion-site dbPET SUVmax (r=0 . 56, R2=0 . 31, p\u003C0 . 05) and the dbPET SUVmax L/H ratio (lesion-to-healthy (normal) -site ratio) (r=0 .47, R2=0 . 22, p\u003C0 . 05) . Additionally, the tissue grade, MMG and ultrasonography categories were positively correlated with dbPET SUVmax. Regarding the lesion detection rate, dbPET identified 100% of the lesions, including benign findings. The dbPET SUVmax L/H ratio showed a trend nearly identical to that of the dbPET SUVmax.  \n*Correspondence: Youko Satou[y-sato@sasaki-geka.jp](y-sato@sasaki-geka.jp)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nSatou et al. BMC Medical Imaging (2026) 26:199 Page 2 of 13  \nConclusions d","cbCaiuZ2Z86yKw5Z","https://ap.wps.com/l/cbCaiuZ2Z86yKw5Z","pdf",2957465,13,"English","# Abstract\n# Background\n# Methods\n## Patient groups and statistical analyses\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What was the study’s main objective?\",\"answer\":\"To determine which patient groups would benefit most from dbPET and how the modality should be utilized, by examining relationships between dbPET SUVmax and clinical, imaging, and pathological factors.\"},{\"question\":\"How many patients were included, and how were they categorized?\",\"answer\":\"The study included 219 breast cancer patients and divided them into three groups: primary care, neoadjuvant therapy, and postoperative follow-up patients.\"},{\"question\":\"What did dbPET show regarding lesion detection and correlations with tumor biology?\",\"answer\":\"dbPET identified 100% of lesions, including benign findings. Ki-67 showed the strongest positive correlation with lesion-site dbPET SUVmax and with the dbPET SUVmax L/H ratio.\"}]","Multicenter prospective study of dedicated breast positron emission tomography (dbPET) for breast cancer - examination in preoperative patients | PDF",1790126527,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/985081daf1ba1f56274107615c8ff6a3.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b326ba4ea5670997e3fa816dc66d58e.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/477a16dd28b2b3ba1522423aaedc0610.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/768986914f275c91cd3ffa73218e5583.webp",980,1306]